HOME >> BIOLOGY >> NEWS
GenVec, U.S. NMRC, and PATH's Malaria Vaccine Initiative partner to expand malaria vaccine efforts

(GAITHERSBURG, MARYLAND--USA, 31 March 2004) - GenVec, Inc. (Nasdaq:GNVC), PATH's Malaria Vaccine Initiative (MVI), and the U.S. Naval Medical Research Center (NMRC) today announced a dynamic partnership to assess whether five malaria antigens, or proteins, can generate strong immune responses alone or in combination. This partnership will advance and expand the ongoing malaria vaccine development program between GenVec and NMRC. Malaria is one of the world's three leading infectious disease killers.

Under a two-year Collaborative Research, Development and Supply Agreement, MVI will provide GenVec up to $2.5 million for the production and evaluation of adenovirus vectors containing genes for up to five malaria antigens. GenVec's proprietary technology uses a replication deficient adenovector to deliver the genes to cause the production of beneficial antigens. Under a separate Collaborative Research and Development Agreement (CRADA) between GenVec and NMRC, NMRC scientists will provide GenVec with optimized malaria genes to be used in the adenovector vaccines. NMRC will then compare the effects of these vaccines alone and in combination in animal models.

Many malaria experts believe that a vaccine containing more than one malaria antigen will be necessary to adequately impact disease. The vaccines will contain the genes for up to five antigens (CSP, SSP2, LSA1, MSP1, and AMA1) from different stages of the parasite's life cycle--antigens thought to be important in preventing or limiting the severity of malaria. GenVec's technology will enable several malaria genes to be delivered in a single vaccine.

"MVI is delighted to be working with GenVec and NMRC on such vital development work," said Dr. Melinda Moree, Director of MVI. "We hope to learn more about which antigens to drive forward and which to halt--a key contribution that MVI can make to move the field ahead. This selection process should give scientists worldwide a better idea about the
'"/>

Contact: Ellen Wilson
301-652-1558 x108
Burness Communications
31-Mar-2004


Page: 1 2

Related biology news :

1. Malaria rise in Africa parallels warming trends
2. Pan-African Malaria Conference November 17-22 in Arusha, Tanzania
3. Multilateral Initiative on Malaria Secretariat to move to Sweden
4. Malaria research and training benefits global community
5. Malaria called failure, puzzle and challenge
6. Multicomponent Malaria Vaccine Shows Promise in Laboratory Tests
7. Christmas Travellers Are Warned Of Malaria Risks
8. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
9. Virginia Tech Scientist Seek Genetic Solution To Malaria
10. Severe Falciparum Malaria Increases In Honduras
11. Curing Malaria, Controlling Mosquitoes Symposium Set For AAAS Meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell is ... nationwide Centers of Excellence. R3 wants patients to feel secure when they make ... patients from Centers that use inferior regenerative biologics, protocols or amounts, R3 provides ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, the broad definition ... this task. Despite this uncertainty, several manufacturers have been successful and numerous follow-on biologics ... of this webinar, learn how analytical similarity is achieved in biosimilars based on recently ...
(Date:3/29/2019)... ... March 29, 2019 , ... ... biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting & Exposition on ... opportunity to connect with academic, healthcare, governmental and business professionals in all aspects ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... , ... March 26, 2019 , ... A leader in ... cell services to veterinarians across the United States and Canada since 2004. The ... and soft tissue injuries in the dog, cat, and horse. Recently, VetStem ...
(Date:3/27/2019)... ... March 27, 2019 , ... Lachman is sponsoring the ... Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site will be available ... two key tracks on the agenda this year. , Executives from Lachman participating at ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... its LenS3 Multi-Angle Light Scattering (MALS) detector , offering a revolutionary approach ... synthetic polymers, polysaccharides, proteins, and biopolymers. A novel optical design, a unique cell-block ...
Breaking Biology Technology:
Cached News: